Natural Product: NPC577073

Natural Product IDNPC577073
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
5,7-dihydroxy-2,8-bis(4-hydroxyphenyl)chromen-4-one
IUPAC Name 5,7-dihydroxy-2,8-bis(4-hydroxyphenyl)chromen-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001615] Flavones

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey YXIOJBQQFQFXDQ-UHFFFAOYSA-N
Standard InCHI InChI=1S/C21H14O6/c22-13-5-1-11(2-6-13)18-10-17(26)20-16(25)9-15(24)19(21(20)27-18)12-3-7-14(23)8-4-12/h1-10,22-25H
SMILES O=C1C=C(C2=CC=C(O)C=C2)OC2=C(C3=CC=C(O)C=C3)C(O)=CC(O)=C12

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   362.08 Volume:   361.287
?
Van der Waals volume.
Dense:   1.002 LogP:   3.611
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.807
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.81
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   2.0 Rigid Bonds:   24.0
TPSA:   111.13
?
Topological Polar Surface Area.
H-Bond Acceptor:   6.0
H-Bond Donor:   4.0 Rings:   4.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.43 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.455 Fsp3:   0.0
MCE-18:   23.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.954 Fluc inhibitor:   0.606
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.94
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.809
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.577 Promiscuous compounds:   0.902

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.156 MDCK Permeability:   -4.755
Pgp-inhibitor:   0.002 Pgp-substrate:   0.198
PAMPA:   0.919
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.656 30% Bioavailability (F30%):   0.675
50% Bioavailability (F50%):   0.981

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.005 MRP1:   0.933
Plasma Protein Binding (PPB):   96.549% Volume Distribution (VD):   -0.465
Fu: 4.116%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.913
OATP1B3 inhibitor:   0.809 BCRP inhibitor:   0.131
BSEP inhibitor:   0.878

ADMET: Metabolism

CYP1A2-inhibitor:   0.014 CYP1A2-substrate:   0.004
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.157 CYP2C9-substrate:   0.631
CYP2D6-inhibitor:   0.998 CYP2D6-substrate:   0.994
CYP3A4-inhibitor:   0.002 CYP3A4-substrate:   0.019
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.675
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  4.222 Half-life (T1/2):  1.551

ADMET: Toxicity

hERG Blockers:  0.063 hERG Blockers (10um):  0.516
Human Hepatotoxicity (H-HT):  0.467 Drug-induced Liver Injury (DILI):  0.787
AMES Toxicity:  0.629 Rat Oral Acute Toxicity:  0.473
Maximum Recommended Daily Dose:  0.872 Skin Sensitization:  0.673
Carcinogencity:  0.752 Eye Corrosion:  0.018
Eye Irritation:  0.99 Respiratory Toxicity:  0.779
Drug-induced Neurotoxicity:  0.071 Ototoxicity:  0.095
Hematotoxicity:  0.048 Drug-induced Nephrotoxicity:  0.052
Genotoxicity:  0.997 RPMI-8226 Immunitoxicity:  0.081
A549 Cytotoxicity:  0.477 Hek293 Cytotoxicity:  0.919
BCF:   1.176
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.111
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.503
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.224
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27558 Podocarpus macrophyllus Species Podocarpaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO27558 Podocarpus macrophyllus Species Podocarpaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO27558 Podocarpus macrophyllus Species Podocarpaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO27558 Podocarpus macrophyllus Species Podocarpaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO27558 Podocarpus macrophyllus Species Podocarpaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC577073 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8889 High Similarity NPC222713
0.7273 Intermediate Similarity NPC67322
0.6897 Remote Similarity NPC138299
0.678 Remote Similarity NPC288840
0.6557 Remote Similarity NPC254351
0.6471 Remote Similarity NPC50898
0.6349 Remote Similarity NPC606549
0.6061 Remote Similarity NPC71061
0.6038 Remote Similarity NPC296197
0.597 Remote Similarity NPC194593
0.5846 Remote Similarity NPC259757
0.5714 Remote Similarity NPC265624
0.5692 Remote Similarity NPC610480
0.5614 Remote Similarity NPC301323
0.5588 Remote Similarity NPC303485
0.5556 Remote Similarity NPC55443
0.5484 Remote Similarity NPC609354
0.5479 Remote Similarity NPC607079
0.5455 Remote Similarity NPC130230
0.541 Remote Similarity NPC610914
0.5405 Remote Similarity NPC604941
0.537 Remote Similarity NPC216318
0.5362 Remote Similarity NPC290830
0.5357 Remote Similarity NPC279121
0.5312 Remote Similarity NPC111112
0.5273 Remote Similarity NPC78540
0.5217 Remote Similarity NPC150908
0.5211 Remote Similarity NPC121649
0.5161 Remote Similarity NPC220062
0.5091 Remote Similarity NPC172262
0.5088 Remote Similarity NPC274121
0.5085 Remote Similarity NPC241498
0.5075 Remote Similarity NPC34089
0.5075 Remote Similarity NPC196179

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC577073 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5357 Remote Similarity NPD1511 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data